fig10
Figure 10. Overall survival (A) and recurrence (B) rates following LT according to rituximab administration in patients with HCC beyond the KC. HCC: Hepatocellular carcinoma; KC: Kyoto criteria; LT: liver transplantation.
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
